Free Trial

Omada Health (OMDA) Competitors

Omada Health logo
$18.50 +0.51 (+2.83%)
As of 07/16/2025 04:00 PM Eastern

OMDA vs. LFST, NHC, GRAL, TDOC, VRDN, AHCO, CDNA, AGL, PNTG, and AVAH

Should you be buying Omada Health stock or one of its competitors? The main competitors of Omada Health include LifeStance Health Group (LFST), National HealthCare (NHC), GRAIL (GRAL), Teladoc Health (TDOC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Agilon Health (AGL), The Pennant Group (PNTG), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

Omada Health vs. Its Competitors

LifeStance Health Group (NASDAQ:LFST) and Omada Health (NASDAQ:OMDA) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

In the previous week, LifeStance Health Group had 3 more articles in the media than Omada Health. MarketBeat recorded 7 mentions for LifeStance Health Group and 4 mentions for Omada Health. LifeStance Health Group's average media sentiment score of 0.59 beat Omada Health's score of 0.47 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Omada Health
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

85.5% of LifeStance Health Group shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Omada Health has lower revenue, but higher earnings than LifeStance Health Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.25B1.37-$57.44M-$0.10-44.00
Omada HealthN/AN/AN/AN/AN/A

LifeStance Health Group currently has a consensus target price of $8.50, indicating a potential upside of 93.18%. Omada Health has a consensus target price of $23.86, indicating a potential upside of 28.96%. Given LifeStance Health Group's higher probable upside, equities analysts plainly believe LifeStance Health Group is more favorable than Omada Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83
Omada Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Omada Health has a net margin of 0.00% compared to LifeStance Health Group's net margin of -2.78%. Omada Health's return on equity of 0.00% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group-2.78% -2.47% -1.69%
Omada Health N/A N/A N/A

Summary

LifeStance Health Group beats Omada Health on 7 of the 12 factors compared between the two stocks.

Get Omada Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMDA vs. The Competition

MetricOmada HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$463.24M$7.13B$5.51B$9.31B
Dividend YieldN/A2.88%4.25%4.09%
P/E RatioN/A24.4628.1219.69
Price / SalesN/A36.87439.46100.25
Price / CashN/A25.3335.5357.53
Price / BookN/A8.218.235.67
Net IncomeN/A$236.06M$3.23B$257.51M
7 Day Performance3.24%-2.28%-0.52%-0.16%
1 Month Performance22.03%1.92%6.71%9.89%
1 Year PerformanceN/A19.29%27.10%15.08%

Omada Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMDA
Omada Health
N/A$18.50
+2.8%
$23.86
+29.0%
N/A$463.24MN/A0.00849Quiet Period Expiration
LFST
LifeStance Health Group
3.0574 of 5 stars
$4.53
+0.3%
$8.50
+87.8%
-22.3%$1.76B$1.28B-45.2510,218
NHC
National HealthCare
N/A$103.50
+0.2%
N/A-22.4%$1.60B$1.37B12.9712,400
GRAL
GRAIL
0.6613 of 5 stars
$40.26
-1.2%
$31.50
-21.8%
+88.2%$1.45B$125.60M-0.661,360
TDOC
Teladoc Health
2.7241 of 5 stars
$8.21
-1.3%
$9.65
+17.5%
-21.7%$1.44B$2.57B-1.395,500
VRDN
Viridian Therapeutics
3.133 of 5 stars
$17.09
+0.3%
$37.56
+119.8%
+5.1%$1.39B$300K-4.4350
AHCO
AdaptHealth
3.8161 of 5 stars
$9.12
-1.1%
$13.40
+47.0%
-19.3%$1.23B$3.26B16.0210,500
CDNA
CareDx
4.1209 of 5 stars
$20.17
+0.2%
$30.33
+50.4%
+3.4%$1.12B$333.79M17.47740
AGL
Agilon Health
2.4091 of 5 stars
$2.23
-0.2%
$4.71
+111.9%
-71.0%$921.04M$6.06B-3.771,076
PNTG
The Pennant Group
3.4741 of 5 stars
$25.34
+0.4%
$34.60
+36.6%
-13.3%$873.50M$695.24M33.347,000Analyst Forecast
AVAH
Aveanna Healthcare
2.0289 of 5 stars
$4.05
-0.4%
$5.20
+28.6%
+8.4%$789.16M$2.09B202.2533,500Analyst Forecast

Related Companies and Tools


This page (NASDAQ:OMDA) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners